Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Xinhong Yu

The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Elicits Cross-Functional Opsonophagocytic Killing Responses in Humans to Streptococcus Pneumoniae Serotypes 6C and 7A

Vaccine

English

Balancing Crystal Size in Small-Molecule Nonfullerene Solar Cells Through Fine-Tuning the Film-Forming Kinetics to Fabricate Interpenetrating Network

English

Related publications

Recommendations for the Prevention of Streptococcus Pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)

English

Public and Private Payer Perspectives on the Net Cost of Implementation of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to in the United States

English

Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population

European Respiratory Journal

English

Clinical Efficacy of Pneumococcal Conjugate 13-Valent Vaccine in Young Children

Pediatric pharmacology

2016

English

A Case Report of Parapneumonic Pleural Effusion Caused by Streptococcus Pneumoniae Serotype 19A in a Child Immunized With 13-Valent Conjugate Pneumococcal Vaccine

English

Pediatric Complicated Pneumonia Caused by Streptococcus Pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015

Emerging Infectious Diseases

English

Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine

Infection and Immunity

English

S72 Paediatric Pneumococcal Empyema Serotypes Have Not Changed Following Introduction of the 13 Valent Pneumococcal Vaccine

English

PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or No Vaccination (NoVac) in the UK

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Xinhong Yu

The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Elicits Cross-Functional Opsonophagocytic Killing Responses in Humans to Streptococcus Pneumoniae Serotypes 6C and 7A

Balancing Crystal Size in Small-Molecule Nonfullerene Solar Cells Through Fine-Tuning the Film-Forming Kinetics to Fabricate Interpenetrating Network

Related publications

Recommendations for the Prevention of Streptococcus Pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)

Public and Private Payer Perspectives on the Net Cost of Implementation of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to in the United States

Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population

Clinical Efficacy of Pneumococcal Conjugate 13-Valent Vaccine in Young Children

A Case Report of Parapneumonic Pleural Effusion Caused by Streptococcus Pneumoniae Serotype 19A in a Child Immunized With 13-Valent Conjugate Pneumococcal Vaccine

Pediatric Complicated Pneumonia Caused by Streptococcus Pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015

Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine

S72 Paediatric Pneumococcal Empyema Serotypes Have Not Changed Following Introduction of the 13 Valent Pneumococcal Vaccine

PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or No Vaccination (NoVac) in the UK